Resverlogix Corp.

(RVX:CA)

By |

Profile

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing RVX-208, a molecule selective inhibit BET domain inhibitor for the treatment of patients with cardiovascular, diabetes mellitus, Alzheimer\'s & chronic kidney disease.

Contact Information

Website: www.resverlogix.com
Main Phone: +1 403 254-9252
Address: 4820 Richard Road S.W.
Address 2: Suite 300
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T3E 6L1

Issuer Information

Exchange: TSX
Employees: 22
NAICS: Biological Produ
$ 1.77 $ 0.05 (2.91%)
Last Price 1.77 Change $ 0.05 Change % 2.91 Tick N/A
Bid 1.77 Bid Size 10,700.00 Ask 1.88 Ask Size 2,300.00
Open 1.75 High 1.81 Low 1.72 Prev Close 1.72
Last Trade Volume 11,047 52 Wk Hi 2.47 52 Wk Low 1.10
Market Cap 186.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 105,426,757.00 EPS (TTM) -0.26 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 07/29/16 07/29/16 07/29/16 07/29/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 1 1